New study results from immunotherapy based treatment strategies

new study results from immunotherapy based treatment strategies

Again, new study results from immunotherapy based treatment strategies have been published and are promising. First-line treatment combining atezolizumab (Tecentriq) and chemotherapy (carboplatin and etoposide) in patients with extensive-stage small cell lung cancer increased survival compared to chemotherapy alone.

http://www.ascopost.com/News/59020

 

IMpower133: Atezolizumab in Combination With Chemotherapy in Previously Untreated, Extensive-Stage Small Cell Lung Cancer- http://www.ascopost.com/News/59020

Leave a Reply

Your email address will not be published. Required fields are marked *